Safety and Efficacy of Nalbuphine, Medetomidine, and Azaperone for Immobilizing Aoudad (Ammotragus lervia). Academic Article

abstract

• We evaluated the safety and efficacy of nalbuphine (40 mg/mL), plus medetomidine (10 mg/mL), plus azaperone (10 mg/mL) under the premixed label NalMed-A. From January to March 2020, 10 aoudad (Ammotragus lervia) were immobilized via dart-gun for seven separate sampling periods for a total of 45 recorded individual immobilization events. Induction and reversal times with NalMed-A were 5.532.61 min and (following atipamezole administration) 5.082.43 min while previous studies with alpha-2 agonist-ketamine combinations gave median and average induction times of 4.6 min and 11.2 min using medetomidine-ketamine and xylazine-ketamine, respectively. Overall, NalMed-A adequately immobilized aoudad, with 13% incidence of hyperthermia and 2.22% mortality when delivered via dart.

authors

• Rech, Raquel

published proceedings

• J Wildl Dis

author list (cited authors)

• Thomas, L. F., Nunez, C. M., Dittmar, R. O., Rech, R. R., Richison, J. J., Lance, W. R., & Cook, W. E.

citation count

• 0

complete list of authors

• Thomas, Logan F||Nunez, Chase M||Dittmar, Robert O||Rech, Raquel R||Richison, Jack J||Lance, William R||Cook, Walter E

publication date

• July 2022

publisher

• Wildlife Disease Association  Publisher

published in

• Journal of Wildlife Diseases  Journal

keywords

• Animals
• Aoudad
• Azaperone
• Barbary Sheep
• Chemical Immobilization
• Drug Combinations
• Hypnotics And Sedatives
• Immobilization
• Induction Time
• Ketamine
• Medetomidine
• Nalbuphine
• Nalmed-a
• Reversal Time
• Ruminants

Digital Object Identifier (DOI)

• 10.7589/JWD-D-21-00120

start page

• 636

end page

• 640

volume

• 58

issue

• 3

URL

• http://dx.doi.org/10.7589/jwd-d-21-00120